Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis

Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis

Concurrent chemoradiotherapy (CCRT) with a cisplatin-based regimen is the standard treatment for patients with nasopharyngeal carcinoma (NPC). Our study was a propensity-score-matching analysis and it aimed to investigate the oncologic outcomes of platinum plus tegafur–uracil versus platinum alone d...

Full description

Bibliographic Details
Main Authors: Ching-Feng Lien, Chien-Chung Wang, Chuan-Chien Yang, Chih-Chun Wang, Tzer-Zen Hwang, Yu-Chen Shih, Shyh-An Yeh, Meng-Che Hsieh
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
tegafur–uracil
chemoradiotherapy
nasopharyngeal carcinoma
prognosis
survival
Online Access:https://www.mdpi.com/2072-6694/14/18/4511

Internet

https://www.mdpi.com/2072-6694/14/18/4511

Similar Items